Contravisory Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Hold
34
﹤0.01% 344
2026
Q1
$12K Hold
34
﹤0.01% 336
2025
Q4
$11.1K Buy
+34
New +$10.8K ﹤0.01% 333
2021
Q1
Sell
-17,706
Closed -$4.07M 263
2020
Q4
$4.07M Sell
17,706
-561
-3% -$129K 1.26% 39
2020
Q3
$4.64M Buy
18,267
+13,562
+288% +$3.36M 1.58% 37
2020
Q2
$1.07M Buy
+4,705
New +$1.07M 0.39% 46
2019
Q2
Sell
-259
Closed -$49K 276
2019
Q1
$49K Hold
259
0.02% 223
2018
Q4
$50K Buy
+259
New +$50.5K 0.02% 196
2017
Q4
Sell
-1,400
Closed -$261K 435
2017
Q3
$261K Hold
1,400
0.09% 115
2017
Q2
$241K Hold
1,400
0.09% 117
2017
Q1
$230K Buy
+1,400
New +$233K 0.08% 97
2016
Q3
Sell
-13
Closed -$2K 279
2016
Q2
$2K Sell
13
-66,630
-100% -$10.4M ﹤0.01% 154
2016
Q1
$9.99M Sell
66,643
-5,880
-8% -$874K 2.92% 5
2015
Q4
$11.8M Sell
72,523
-17,435
-19% -$2.74M 3.13% 5
2015
Q3
$12.4M Sell
89,958
-1,432
-2% -$226K 2.92% 6
2015
Q2
$14M Sell
91,390
-7,020
-7% -$1.12M 3.05% 6
2015
Q1
$15.7M Sell
98,410
-2,593
-3% -$408K 3.16% 7
2014
Q4
$16.1M Sell
101,003
-4,250
-4% -$662K 3.25% 3
2014
Q3
$14.8M Sell
105,253
-6,918
-6% -$903K 3.08% 6
2014
Q2
$13.3M Sell
112,171
-5,312
-5% -$615K 2.62% 14
2014
Q1
$14.5M Sell
117,483
-763
-0.6% -$92.5K 2.84% 9
2013
Q4
$13.5M Sell
118,246
-993
-0.8% -$113K 2.59% 13
2013
Q3
$13.3M Buy
119,239
+130
+0.1% +$14.1K 2.78% 8
2013
Q2
$11.8M Buy
+119,109
New +$12.4M 2.61% 10

Other funds holding AMGN

Contravisory Investment Management's AMGN Position: Q2 2026 in Review

Contravisory Investment Management held its Amgen (AMGN) position steady in Q2 2026 at 34 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #344.

Contravisory Investment Management first reported a position in AMGN in Q2 2013 and has held it in 24 quarters since. The position peaked at $16.1M in Q4 2014. 1,208 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Contravisory Investment Management held 34 shares of Amgen worth $12.3K as of Q2 2026.
  • Contravisory Investment Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of Contravisory Investment Management's portfolio in Q2 2026, its #344 holding.
  • Contravisory Investment Management first reported a position in Amgen in Q2 2013 and has held it in 24 quarters since.
  • Contravisory Investment Management's Amgen position peaked at $16.1M in Q4 2014.
  • 1,208 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.